JOE TAYLOR: Open Payments
NPI 1851347215 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,734 in 47 payments from 11 companies in 2025. Trend: 2023 $8,543 · 2024 $4,915 · 2025 $8,734
Speaker / faculty: $7,500Food & beverage: $1,161Travel & lodging: $73
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $7,978 |
| AstraZeneca Pharmaceuticals LP | 4 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $140 |
| Otsuka America Pharmaceutical, Inc. | 2 | $105 |
| Lundbeck LLC | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Corium, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $34 |
| CSL Behring | 1 | $23 |
Products named: VRAYLAR, REXULTI, AIRSUPRA, CAPLYTA, FARXIGA, FANAPT, Auvelity, Azstarys.
Industry payments across LA — which companies pay providers there.
